SCHEMBL7428890

SCHEMBL7428890

CCCc1ccc[c]c1CC(C)C

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7428726 0.90 GABRA1 (0.35) GABRA1GABRB2
SCHEMBL7434150 0.88 LIPG (0.40) GABRA1GABRB2
SCHEMBL7434000 0.87 LIPG (0.42)
SCHEMBL310156 0.85 GABRA1 (0.47) GABRA1GABRB2
SCHEMBL7426926 0.83 SIGMAR1 (0.38)
SCHEMBL381275 0.83 DAO (0.31)
SCHEMBL6339207 0.81 MGLL (0.34) GABRA1GABRB2
SCHEMBL815763 0.78 LIPG (0.34)
SCHEMBL2661090 0.77 KCNH2 (0.38)
SCHEMBL816546 0.76 LIPG (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212306-A2 HYDROXYALKANOYLAMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF ABETA PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2002-06-12 EP disclosed
EP-1137649-A2 PROCESS FOR THE PREPARATION OF PYRIMIDINONE DERIVATIVES Syngenta Participations AG (CH) 2001-10-04 EP disclosed
WO-2001019797-A2 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION DU PONT PHARMACEUTICALS COMPANY (US) 2001-03-22 WO disclosed
WO-2000034286-A2 PROCESS FOR THE PREPARATION OF PYRIMIDINONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2000-06-15 WO disclosed